This message was sent to ##Email##
|
|
|
|
|
| |
By Dr. Abimbola Farinde
 The general public may not fully understand the importance and potential benefits of biosimilars, but this class of agents is slowly gaining attention as therapeutic options for chronic or life-threatening conditions and disease states. Many patients are not aware of biosimilars and their capabilities, because biosimilars have not actually existed on American shores for long. By the time the first biosimilar was approved in the U.S. in the summer of 2015, Europe had already approved 19.
READ MORE
2017 Fall Conference
Sept. 16 — Phoenix, Arizona
For more information and a tentative agenda, click here.
Registration coming soon.
Masquerade Ball 2017
Sept. 30 — Chandler, Arizona
You can register by clicking here!
AzPA Immunization Delivery Training Program
Sept. 30-Oct. 1 — Glendale, Arizona
Registration coming soon.
Pharmacy Practice News
Approximately 1 in 4 adults prescribed an antibiotic in an outpatient setting for community-acquired pneumonia did not respond to treatment, according to a new study.
READ MORE
APhA
Multiple factors contribute to the decision not to take osteoporosis medications, with fear of adverse events topping the list, say researchers in a paper published online in the Journal of the American Pharmacists Association.
READ MORE
Hospital for Specialty Surgery via ScienceDaily
In the first such collaboration of its kind, an expert panel of rheumatologists and orthopedic surgeons has developed guidelines for the perioperative management of anti-rheumatic medication in patients undergoing total hip or knee replacement. The guidelines aim to reduce the risk of infection after joint replacement.
READ MORE
Medical News Today
A combination of vitamin C and antibiotics could be key to killing cancer stem cells, a new study finds, paving the way for a strategy that could combat cancer recurrence and treatment resistance.
READ MORE
APhA
In May, Oregon Gov. Kate Brown signed into law a bill that allows pharmacists to prescribe and dispense drugs or devices without a physician’s prescription, provided that a health professional has already made a relevant diagnosis and the drugs or devices are on a formulary to be established by an executive committee of allied health professionals. The law expands the previous Public Health Advisory Committee and renames it the Public Health and Pharmacy Formulary Advisory Committee to reflect the inclusion of three pharmacists along with two physicians and two nurse practitioners.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
Oncology Nurse Advisor
Oral cancer therapies are creating a paradigm shift in how antineoplastic medications are administered. Navigators need to find the technology that suits the patient best to ensure adherence to the oral cancer therapy regimen, according to a presentation at the 2017 Oncology Nurse Advisor Navigation Summit.
READ MORE
Pharmacy Times
As many of us pharmacists may know, we are the epitome of a Type-A personality — we strive for perfection, giving our 110 percent, and being the absolute best we can be of ourselves. We genuinely want the best for our patients, and we want to deliver the best care possible, no stone left unturned. Enter stage left reality: things are never perfect, and what’s that thing? Oh yea, life happens.
READ MORE
The New England Journal of Medicine
Degludec is an ultralong-acting, once-daily basal insulin that is approved for use in adults, adolescents, and children with diabetes. Previous open-label studies have shown lower day-to-day variability in the glucose-lowering effect and lower rates of hypoglycemia among patients who received degludec than among those who received basal insulin glargine. However, data are lacking on the cardiovascular safety of degludec.
READ MORE
Wired
One in 5 Americans takes more than three medications a day, according to the Centers for Disease Control. The World Health Organization estimates that roughly 50 percent of patients in the U.S. with chronic illnesses don’t take that medication exactly as prescribed — mistakes that can be deadly. A review in the Annals of Internal Medicine estimated the problem accounts for 125,000 deaths a year in the U.S. When you miss doses, not only is your individual treatment compromised, but it becomes harder for doctors to diagnose your symptoms and for researchers to accurately track the long-term effects of medications.
READ MORE
|
|
|
|
50 Minthorn Blvd.Suite 800, Thornhill, Ontario L3T 7X8
|
